What should be the primary target of "treat to target" in psoriatic arthritis?

What should be the primary target of "treat to target" in psoriatic arthritis?

<h4>Background</h4> <p>Treat to Target in psoriatic arthritis (PsA) recommendations have stated that the target should be remission or inactive disease. Potential definitions include Very Low Disease Activity (VLDA), PsA Disease Activity Score (PASDAS) near remission, Disease Act...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Coates, LC, Lubrano, E, Perrotta, FM, Emery, P, Conaghan, PG, Helliwell, PS
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	Journal of Rheumatology 2018

Gelijkaardige items

What should be the primary target of ‘treat to target’ in PsA?
door: Coates, L, et al.
Gepubliceerd in: (2018)

Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era
door: Coates, L, et al.
Gepubliceerd in: (2022)

Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial
door: Coates, L, et al.
Gepubliceerd in: (2019)

Sustained very low disease activity and remission in psoriatic arthritis patients
door: Lubrano, E, et al.
Gepubliceerd in: (2019)

New approved drugs for psoriatic arthritis
door: F.M. Perrotta, et al.
Gepubliceerd in: (2016-09-01)

Precision medicine in psoriatic arthritis: how should we select targeted therapies?
door: Al-Mossawi, H, et al.
Gepubliceerd in: (2019)

Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients
door: Ennio Lubrano, et al.
Gepubliceerd in: (2019-08-01)

How should we define disease and outcomes in axial psoriatic arthritis?
door: Coates, LC
Gepubliceerd in: (2021)

Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
door: Ennio Lubrano, et al.
Gepubliceerd in: (2023-07-01)

THE DIAGNOSIS OF PSORIATIC ARTHRITIS
door: P.S. Helliwell
Gepubliceerd in: (2011-09-01)

The dynamics of response as measured by multiple composite outcome tools in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial.
door: Coates, L, et al.
Gepubliceerd in: (2017)

Does treat to target or achieving remission improve radiographic outcome in psa?
door: Coates, L, et al.
Gepubliceerd in: (2016)

Simulation-based design of pragmatic trials in psoriatic arthritis using propensity scores
door: Weinstein, SM, et al.
Gepubliceerd in: (2021)

Mixed methods study of clinicians’ perspectives on barriers to implementation of treat to target in psoriatic arthritis
door: Dures, E, et al.
Gepubliceerd in: (2020)

Novel concepts in psoriatic arthritis management: Can we treat to target?
door: Tucker, L, et al.
Gepubliceerd in: (2018)

Comparing the visual analogue scale and the numerical rating scale in patient-reported outcomes in psoriatic arthritis
door: Ye, W, et al.
Gepubliceerd in: (2021)

Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo
door: Gladman, DD, et al.
Gepubliceerd in: (2022)

The comparative performance of three screening questionnaires for psoriatic arthritis in a primary care surveillance study
door: Helliwell, PS, et al.
Gepubliceerd in: (2023)

Assessment of patient-physician interactions in psoriatic arthritis: national results of the ASSIST Study
door: Perrotta, FM, et al.
Gepubliceerd in: (2024)

Measuring physical function in psoriatic arthritis: comparing the Multi-Dimensional Health Assessment Questionnaire to the Health Assessment Questionnaire Disability Index
door: Ye, W, et al.
Gepubliceerd in: (2021)

Occult axial involvement in patients with psoriatic arthritis mutilans: a case report
door: F.M. Perrotta, et al.
Gepubliceerd in: (2019-07-01)

Current concepts and unmet needs in psoriatic arthritis
door: Mahmood, F, et al.
Gepubliceerd in: (2017)

Psoriatic arthritis: prospects for the future
door: Hackett, S, et al.
Gepubliceerd in: (2022)

Should methotrexate have any place in the treatment of psoriatic arthritis?
door: Ye, W, et al.
Gepubliceerd in: (2019)

Evaluation and validation of a patient completed psoriatic arthritis flare questionnaire
door: Helliwell, PS, et al.
Gepubliceerd in: (2021)

Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
door: Coates, L, et al.
Gepubliceerd in: (2016)

Measuring outcomes in psoriatic arthritis
door: Ogdie, A, et al.
Gepubliceerd in: (2020)

Outcome measures in psoriatic arthritis: where next?
door: Hackett, S, et al.
Gepubliceerd in: (2022)

Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective
door: Ennio Lubrano, et al.
Gepubliceerd in: (2022-12-01)

Assessing disease activity in psoriatic arthritis: a literature review
door: Tucker, L, et al.
Gepubliceerd in: (2018)

Psoriatic arthritis: lessons from imaging studies and implications for therapy
door: Mathew, A, et al.
Gepubliceerd in: (2016)

Treatment to target in psoriatic arthritis with apremilast: probability of achieving targets and comprehensive control of disease manifestations
door: Mease, PJ, et al.
Gepubliceerd in: (2020)

Comparing psoriatic arthritis low-field magnetic resonance imaging, ultrasound and clinical outcomes: data from the TICOPA trial
door: Helliwell, P, et al.
Gepubliceerd in: (2019)

Cost-effectiveness of tight control of inflammation in early psoriatic arthritis: economic analysis of a multicenter randomized controlled trial
door: O'Dwyer, J, et al.
Gepubliceerd in: (2018)

Identification of psoriatic arthritis in patients with psoriasis
door: Coates, LC, et al.
Gepubliceerd in: (2023)

GRAPPA 2021 treatment recommendations for psoriatic arthritis
door: Soriano, ER, et al.
Gepubliceerd in: (2023)

Remission in psoriatic arthritis—where are we now?
door: Coates, L, et al.
Gepubliceerd in: (2017)

Psoriatic arthritis: imaging techniques
door: E. Lubrano, et al.
Gepubliceerd in: (2012-06-01)

Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumab
door: Coates, L, et al.
Gepubliceerd in: (2018)

Psoriatic arthritis
door: FitzGerald, O, et al.
Gepubliceerd in: (2021)